A detailed history of Pluribus Labs, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Pluribus Labs, LLC holds 4,998 shares of DXCM stock, worth $400,039. This represents 0.68% of its overall portfolio holdings.

Number of Shares
4,998
Previous 554 802.17%
Holding current value
$400,039
Previous $283,000 31.8%
% of portfolio
0.68%
Previous 1.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $302,147 - $590,563
4,444 Added 802.17%
4,998 $373,000
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $52,120 - $72,130
554 New
554 $283,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Pluribus Labs, LLC Portfolio

Follow Pluribus Labs, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pluribus Labs, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pluribus Labs, LLC with notifications on news.